CIMSA Fair Value & Analysis
Basic Materials · Market cap 42.3B TRY
Fair value as of: Aug 6, 2026
From 20 valuation models · updated today
Share price −7.3% over the past month.
Below-average quality, screening 25% undervalued on our models.
What matters now
- Our model range runs from 41.83 TRY (bear) to 69.71 TRY (bull), base 55.77 TRY. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 36/100 (below-average quality) with medium evidence: read the verdict with care.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 6, 2026.
How to read this chart
60‑month range 2.63 TRY – 59.00 TRY · fair‑value band 41.83 TRY – 69.71 TRY · the 44.74 TRY price screens below the 55.77 TRY fair value. Dashed = 300-day average. As of Aug 6, 2026.
Analysis
CIMSA (CIMSA) currently trades at 44.74 TRY, while our model-based Fair Value estimate is 55.77 TRY, implying the stock looks roughly 24.7% undervalued today. We read business quality at 36/100 (below-average quality), in the Basic Materials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, CIMSA generated revenue of 45.9B TRY at a net margin of 7.4%. Revenue declined 0.2% year over year. It earns a return on equity of 10.5%. Net debt stands at 18.2B TRY. Fundamentals as of Aug 6, 2026
Our scenario range runs from 41.83 TRY (bear case) to 69.71 TRY (bull case); at 44.74 TRY, the current price sits within that range. The share trades about 25% below its 52-week high and 10% above its 52-week low, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -59% fair-value upside, at 25%, CIMSA screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 20 models by family
Widest divergence: Growth Earnings (103.93 TRY) versus Asset-Based (23.54 TRY). Highest evidence: Residual Income (76).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 6, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 37 · Market factors (momentum, volatility) 41
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
CIMSA reported revenue of 45.9B TRL in FY2025 versus 3.7B TRL in FY2021, a compound +87.1%/yr. Reported net income was 3.1B TRL in FY2025, compounding +32.2%/yr from FY2021.
Watch CIMSA: get an alert when its fair value changes →
Peer Group
Building Materials · 255 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Building Materials median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Building Materials stocks, each showing price versus our Fair Value estimate (as of Aug 6, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| CRH plc CRH | $102.92 | $70.57 | -31% |
| UltraTech Cement Limited ULTRACEMCO | ₹11,711 | ₹4,719 | -60% |
| China Jushi Co 600176 | ¥54.52 | ¥13.95 | -74% |
| Grasim Industries Limited GRASIM | ₹3,073 | ₹1,245 | -59% |
| CEMEX, S.A. CEMEXCPO | 21.71 MXN | 15.42 MXN | -29% |
| Anhui Conch Cement Company 600585 | ¥16.99 | ¥26.14 | +54% |
| Ambuja Cements Limited AMBUJACEM | ₹435.25 | ₹227.96 | -48% |
| Shree Cement Limited SHREECEM | ₹26,930 | ₹8,215 | -69% |
| TCC Group 1101B | 43.70 TWD | 10.48 TWD | -76% |
| Taiwan Glass Ind. Corp 1802 | 53.30 TWD | 13.98 TWD | -74% |
Compare CIMSA with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is CIMSA overvalued or undervalued?
What is the fair value of CIMSA?
What is the quality score of CIMSA?
What is the revenue of CIMSA?
What is the net profit margin of CIMSA?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track CIMSA and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.